Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SATRALIZUMAB vs SCOPOLAMINE HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SATRALIZUMAB vs SCOPOLAMINE HYDROBROMIDE: Safety Overview

Metric SATRALIZUMAB SCOPOLAMINE HYDROBROMIDE
Total FAERS Reports 219 298
Deaths Reported 16 50
Death Rate 7.3% 16.8%
Hospitalizations 108 91
Average Patient Age 51.6 yrs 48.5 yrs
% Female Patients 82.1% 67.7%
Manufacturer Genentech, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A